Imagion Biosystems Limited provides medical imaging technologies using magnetic resonance. It has activities in nanotechnology; biotechnology; cancer diagnostics; and superparamagnetic relaxometry. The company develops MagSense, which is in Phase I clinical trials for the treatment of HER2 breast cancers; and PrecisionMRX, an iron oxide nanoparticle to detect cancer. Imagion Biosystems Limited has a collaborative research program with Patrys Limited to use the MagSense nanoparticles for enhancing brain tumor imaging and diagnosis. The company was incorporated in 2016 and is based in San Diego, California.
| Market Capitalization | $18.2807 million |
| P/E Ratio | 0 |
| P/E Growth Ratio | |
| Book Value | -0.001 |
| Dividend Per Share | 0 |
| Earnings Per Share | -0.01 |
| EBITDA | -10,969.974 |
| Profit Margin | 0 |
| Operating Margin TTM | -3.1998 |
| Return on Assets TTM | -0.697 |
| Return on Equity TTM | -3.5037 |
| Revenue TTM | 3,495.174 |
All numbers are in thousands
| Date | Total Revenue | Cost of Revenue | Gross Profit | Total Operating Expenses |
|---|---|---|---|---|
| 2014-12-31 | 5 | 0 | 5 | 1,903 |
| 2015-12-31 | 4 | 0 | 4 | 3,008 |
| 2016-12-31 | 0.012 | 0 | 0.012 | 6,798.864 |
| 2017-12-31 | 20.102 | 0 | 20.102 | 7,197.865 |
| 2018-12-31 | 191.477 | 0 | 191.477 | 9,148.641 |
| 2019-12-31 | 410.854 | 410.854 | 5,880.511 | |
| 2020-12-31 | 205.717 | 205.717 | 7,955.836 | |
| 2021-12-31 | 232.865 | 232.865 | 8,870.492 | |
| 2022-12-31 | 473.429 | 473.429 | 12,702.394 |
All numbers are in thousands
| Date | Cash | Total Assets | Total Liabilities | Short Term Debt | Long Term Debt | Common Stock |
|---|---|---|---|---|---|---|
| 2014-12-31 | 133 | 277 | 3,527 | 3,428 | 2,500 | 60 |
| 2015-12-31 | 283 | 574 | 7,029 | 6,914 | 2,500 | 60 |
| 2016-12-31 | 11,913.941 | 12,141.642 | 451.993 | 11,017.95 | 30,104.547 | |
| 2017-12-31 | 6,872.829 | 7,641.326 | 688.77 | 30.684 | 28,686.708 | |
| 2018-12-31 | 4,367.097 | 5,187.459 | 1,318.231 | 36.082 | 33,182.325 | |
| 2019-12-31 | 3,401.713 | 4,872.097 | 1,898.58 | 261.76 | 36,904.58 | |
| 2020-12-31 | 13,200.547 | 14,119.004 | 1,205.137 | 358.23 | 51,322.126 | |
| 2021-12-31 | 13,393.768 | 14,115.155 | 809.876 | 15.141 | 56,827.608 | |
| 2022-12-31 | 4,446.102 | 9,975.622 | 5,298.126 | 1,041.051 | 56,830.408 |
All numbers are in thousands
| Date | Net Income | Total Cash | Change in Cash | Begin period cash | End period cash | Dividends |
|---|---|---|---|---|---|---|
| 2014-12-31 | -2,058 | -1,989 | -246 | |||
| 2015-12-31 | -3,205 | -3,076 | 150 | |||
| 2016-12-31 | -12,413.724 | -3,207.072 | 27.64 | 27.641 | ||
| 2017-12-31 | -7,794.602 | -6,977.385 | 6,845.188 | 27.641 | 6,872.829 | |
| 2018-12-31 | -8,340.013 | -6,567.21 | -2,505.732 | 6,872.829 | 4,367.097 | |
| 2019-12-31 | -3,441.664 | -4,182.045 | -965.384 | 4,367.097 | 3,401.713 | |
| 2020-12-31 | -5,370.472 | -4,623.09 | 9,798.834 | 3,401.713 | 13,200.547 | |
| 2021-12-31 | -6,024.706 | -5,068.491 | 193.221 | 13,200.547 | 13,393.768 | |
| 2022-12-31 | -9,809.193 | -8,701.01 | -8,947.665 | 13,393.768 | 4,446.103 |